Share buyback nod fails to lift Ajanta Pharma; falls 7% on weak Q3 results
The stock dipped 7 per cent to Rs 1,016 on BSE after the company's consolidated net profit more-than-halved at Rs 67 crore in Q3FY19, due to lower sales.
The stock dipped 7 per cent to Rs 1,016 on BSE after the company's consolidated net profit more-than-halved at Rs 67 crore in Q3FY19, due to lower sales. http://bit.ly/2S12Usi January 30, 2019 at 08:48PM
The stock dipped 7 per cent to Rs 1,016 on BSE after the company's consolidated net profit more-than-halved at Rs 67 crore in Q3FY19, due to lower sales. http://bit.ly/2S12Usi January 30, 2019 at 08:48PM
Comments
Post a Comment